Randomized Controlld Trial of Dementia Education Resources for Action
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorGeorge Mason University
About this trial
The goal of this intervention trial is to evaluate the effectiveness the online training program Dementia Education and Resources for Action (DERA) in improving Alzheimer's disease and related dementia-(ADRD) knowledge, stigma, and service-related self-efficacy among community health workers (CHWs). We hypothesize that participants who have completed the DERA will have improved ADRD knowledge and self-efficacy in related service and reduced stigma against ADRD and people affected.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age 18 years or older
Currently working as a community health worker or serving in a community health worker-related role
Able to read and understand English
Has access to the internet and a computer, tablet, or smartphone to complete the online training and surveys
Disqualifiers
Previously completed the DERA training program
Unable to complete study procedures in English
Unable to access the online training platform or study surveys
Trial design
Design model
Parallel
Treatments tested in this trial
DERA Online Training Program
BehavioralThe Dementia Education and Resources for Action (DERA) program is a structured, online training intervention designed for community health workers. The program consists of approximately 7 sessions delivered through a web-based platform. Content includes dementia fundamentals, early signs and risk factors, stigma reduction, and strategies for communication, support, and service navigation. The training incorporates video-based instruction, interactive materials, and quizzes to support learning and engagement.
Treatment groups
100 Participants
are divided into 2 treatment groupsGroup A: Immediate DERA InterventionExperimental treatment 1 intervention
Group B: Waitlist ControlNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Dementia Knowledge
Dementia knowledge will be assessed using the Dementia Knowledge Assessment Scale (DKAS). The DKAS is a validated instrument that measures knowledge across multiple domains, including causes, symptoms, risk factors, and care considerations. DKAS-25 total score ranges from 0 to 50. Items are scored 0-2, with higher scores indicating greater dementia-related knowledge.
Time frame
Baseline to post-intervention (approximately 6-8 weeks)Secondary outcomes
1
Dementia-Related Stigma
Dementia-related stigma will be assessed using an adapted 8-item stigma scale with response options ranging from strongly disagree to strongly agree. Total scores range from 8 to 40, with higher scores indicating greater dementia-related stigma.
Time frame
Baseline to post-intervention (approximately 6-8 weeks)2
Self-Efficacy in Dementia Care
Self-efficacy will be measured using a study-specific Community Health Worker Dementia Role Self-Efficacy Scale assessing confidence in performing dementia-related tasks, including education, communication, support, and service navigation. Response options range from "Not at all confident" to "Extremely confident." Total scores range from 8 to 40, with higher scores indicating greater self-efficacy in dementia-related service delivery.
Time frame
Baseline to post-intervention (approximately 6-8 weeks)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov